CONSTANT LEVERAGE SHORT - PFIZER INC Share Price

Certificat

XL7NB

NLBNPNL2QL88

Real-time Euronext Paris 14:14:44 17/05/2024 BST
3.03 EUR +0.33% Intraday chart for CONSTANT LEVERAGE SHORT - PFIZER INC
Current month-36.22%
1 month-36.08%
Date Price Change
17/05/24 3.03 +0.33%
16/05/24 3.02 +1.00%
15/05/24 2.99 -7.43%
14/05/24 3.23 +0.62%
13/05/24 3.21 -3.31%

Real-time Euronext Paris

Last update May 17, 2024 at 02:14 pm

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
XL7NB
ISINNLBNPNL2QL88
Date issued 15/04/2024
Maturity Unlimited
Parity 1 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.11
Lowest since issue 2.99
Spread 0.1
Spread %3.27%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92 USD
Average target price
31.94 USD
Spread / Average Target
+10.44%
Consensus
  1. Stock Market
  2. Certificates
  3. XL7NB Certificat